Airway Management in Children Undergoing Adenotonsillectomies
2 other identifiers
interventional
128
1 country
1
Brief Summary
Secure airway management is the basis of all anesthesiological practice. Of particular importance is the securing of patients' airway passages when the surgical procedure itself poses a threat to a patient's airway, as is the case in all procedures involving the upper respiratory pathways. When adenoidectomies, tonsillectomies and combined adenotonsillectomies are performed, blood from the surgical area will present a respiratory threat to unsecured airways. The traditional opinion has been that endotracheal intubation is the safest method of preventing aspiration. The laryngeal mask was introduced in 1983 as an alternative to the endotracheal tube. In 1990, the flexible, reinforced laryngeal mask airway was introduced, intended for use during surgical procedures involving the mouth and throat. The laryngeal mask airway has several potential advantages over the endotracheal tube. It is inserted blindly, without laryngoscopy. This leads to reduced oropharyngeal or laryngeal stimulation and injury, and therefore minimal activation of respiratory and circulatory reflexes. The laryngeal mask airway can be placed without the use of muscle relaxants, avoiding potential side effects such as apnea, hyperkalemia and anaphylaxis. In addition the laryngeal mask airway can remain in the throat until the patient awakes, virtually eliminating the danger of postoperative aspiration. Several international studies have described the advantages of the laryngeal mask airway over endotracheal intubation during ear, nose and throat surgery in children. The general impression is that there is a widespread routine implementation of the laryngeal mask airway. In Norway, however, this practice has been limited. As far as we know, only Namsos Hospital uses this procedure as its first choice. At Telemark Hospital we tested the use of laryngeal mask airway on 150 patients between May and December 2006. The results so far have been promising, and we have had no serious complications. Hypothesis: In children undergoing adenotonsillectomies, a laryngeal mask airway provides greater patient satisfaction (judged by reduced pain, nausea and vomiting) and greater effectivity (judged by reduced time in surgery), compared with the endotracheal tube. The laryngeal mask provides as much as or greater secure airway management measured by desaturations/Sp02\<92% and/or use of suxamethonium and bronchiolytic drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 10, 2007
CompletedFirst Posted
Study publicly available on registry
December 11, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedJanuary 15, 2009
January 1, 2009
1.4 years
December 10, 2007
January 14, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
Patient satisfaction: a) Pain (VAS, use of opioids), b) Nausea and vomiting (score)
24 hrs
Secondary Outcomes (2)
Effectivity (judged by reduced time in surgery)
1 hrs
Secure airway management measured by desaturations/Sp02<92% and/or use of suxamethonium and bronchiolytic drugs.
24 hrs
Study Arms (2)
1
ACTIVE COMPARATORLaryngeal mask airway (LMA)
2
ACTIVE COMPARATOREndotracheal tube (ETT)
Interventions
Airway management by the use of the flexible, reinforced laryngeal mask airway
Eligibility Criteria
You may qualify if:
- Children 10-60 kg
- Elective adenotomy, tonsillectomy or combined adenotonsillectomy under general anesthesia.
- Written and oral informed parental consent.
You may not qualify if:
- ASA III or higher.
- Weight \< 10 kg or weight \> 60 kg.
- Congenital malformations of the mouth or throat.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sykehuset Telemark, Clinic of emergency medicin
Porsgrunn, Telemark, 3913, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simen Doksrød, MD
Sykehuset Telemark
- STUDY DIRECTOR
Peter Heidt, PhD
Namsos Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 10, 2007
First Posted
December 11, 2007
Study Start
March 1, 2007
Primary Completion
August 1, 2008
Study Completion
August 1, 2008
Last Updated
January 15, 2009
Record last verified: 2009-01